John J Waters insider trades: Nutex Health (NUTX) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where John reports to the SEC
Open-market buys and sales
4 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| May 18, 2023 | NUTX | ↑ Buy | 50,000 | $0.47 | $23K | Direct | May 18, 2023 (0d) |
| Aug 12, 2020 | CLNH | ↑ Buy | 31,746 | $20000.00 | $634.9M | Direct | Sep 9, 2020 (28d) |
| Mar 31, 2009 | ADAT | ↑ Buy | 370,000 | $101750.00 | $37.65B | Direct | Apr 2, 2009 (2d) |
| Sep 30, 2005 | ADAT | ↑ Buy | 10,000 | $2.49 | $25K | By spouse | Sep 30, 2005 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other NUTX insiders
Open-market trades in the last 12 months
About John J Waters's insider trades
John J Waters is a director at Nutex Health (NUTX). Since Sep 30, 2005, John has reported 4 open-market purchases worth $38.28B and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (39 filings), other transactions (3 filings), conversions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every NUTX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.